Perception of oral corticosteroids in adult patients with asthma in France

References

• Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Mulpuru S. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317(3):269–279. doi:10.1001/jama.2016.19627.
   PubMed Web of Science ®Google Scholar
• Al Efraij K, Johnson KM, Wiebe D, Sadatsafavi M, FitzGerald JM. A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma. J Asthma. 2019;56(12):1334–1346.
   PubMed Web of Science ®Google Scholar
• Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371(13):1189–1197. doi:10.1056/NEJMoa1403291.
   PubMed Web of Science ®Google Scholar
• Benard-Laribiere A, Pariente A, Pambrun E, Begaud B, Fardet L, Noize P. Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France. BMJ Open. 2017;7(7):e015905. doi:10.1136/bmjopen-2017-015905.
   PubMed Web of Science ®Google Scholar
• Berthon BS, MacDonald-Wicks LK, Wood LG. A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans. Nutr Res. 2014;34(3):179–190. doi:10.1016/j.nutres.2013.12.006.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkstrom V, et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016;388(10056):2115–2127. doi:10.1016/S0140-6736(16)31324-1.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Menzies-Gow AN, Price DB, Bourdin A, Sweet S, Martin AL, Alacqua M, Tran TN. Systematic literature review of systemic corticosteroid use for asthma management. Am J Respir Crit Care Med. 2020;201(3):276–293. [Epub ahead of print]. doi:10.1164/rccm.201904-0903SO.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Fabry-Vendrand C, Ostinelli J, Ait-Yahia M, Darnal E, Bouee S, Laurendeau C, Bureau I, Gourmelen J, Chouaid C. The burden of severe asthma in France: a case-control study using a medical claims database. J Allergy Clin Immunol Pract. 2019;7(5):1477–1487. doi:10.1016/j.jaip.2018.12.029.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Molinari N, Vachier I, Pahus L, Suehs C, Chanez P. Mortality: a neglected outcome in OCS-treated severe asthma. Eur Respir J. 2017;50(5):1701486. doi:10.1183/13993003.01486-2017.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033–1039. doi:10.1056/NEJM199010113231505.
   PubMed Web of Science ®Google Scholar
• Busse WW, Maspero JF, Rabe KF, Papi A, Wenzel SE, Ford LB, Pavord ID, Zhang B, Staudinger H, Pirozzi G, et al. Liberty Asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma. Adv Ther. 2018;35(5):737–748. doi:10.1007/s12325-018-0702-4.
   PubMed Web of Science ®Google Scholar
• Chapman KR, Verbeek PR, White JG, Rebuck AS. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med. 1991;324(12):788–794. doi:10.1056/NEJM199103213241202.
   PubMed Web of Science ®Google Scholar
• Chung LP, Upham JW, Bardin PG, Hew M. Rational oral corticosteroid use in adult severe asthma: A narrative review. Respirology. 2020;25(2):161–172. doi:10.1111/resp.13730.
   PubMed Web of Science ®Google Scholar
• Cooper V, Metcalf L, Versnel J, Upton J, Walker S, Horne R. Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim Care Respir Med. 2015;25:15026.
   PubMed Web of Science ®Google Scholar
• Costello R, Patel R, Humphreys J, McBeth J, Dixon WG. Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community. BMJ Open. 2017;7(4):e014603. doi:10.1136/bmjopen-2016-014603.
   PubMed Web of Science ®Google Scholar
• Ellis A. The pathological anatomy of bronchial asthma. Am J Med Sci. 1908;136:407–429.
   Google Scholar
• Eurostat. Internet use by individuals 2019. [Last accessed: 30 January 2019]. https://ec.europa.eu/eurostat/search?p_auth=RJlCSCPp&p_p_id=estatsearchportlet_WAR_estatsearchportlet&p_p_lifecycle=1&p_p_state=maximized&p_p_mode=view&_estatsearchportlet_WAR_estatsearchportlet_action=search&text=Internet+use+by+individuals.
   Google Scholar
• FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, et al. Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2016;388(10056):2128–2141. doi:10.1016/S0140-6736(16)31322-8.
   PubMed Web of Science ®Google Scholar
• Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2009;180(9):817–822. doi:10.1164/rccm.200902-0166OC.
   PubMed Web of Science ®Google Scholar
• Global Asthma Network (GAN) Steering Group. The Global Asthma Report 2014 [Last accessed: 30 January 2019]. https://www.globalasthmareport.org/2014/about/executive.php.
   Google Scholar
• Global Initiative for Asthma. GINA report, global strategy for asthma management and prevention 2018 [Last accessed: 30 January 2019]. https://ginasthma.org/gina-reports/.
   Google Scholar
• Hamilton D, Lehman H. Asthma phenotypes as a guide for current and future biologic therapies. Clin Rev Allergy Immunol. 2019. doi:10.1007/s12016-019-08760-x.
   PubMed Web of Science ®Google Scholar
• Hench PS, Kendall EC, et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin. 1949;24:181–197.
   PubMed Web of Science ®Google Scholar
• Lee J, Tay TR, Radhakrishna N, Hore-Lacy F, Mackay A, Hoy R, Dabscheck E, O'Hehir R, Hew M. Nonadherence in the era of severe asthma biologics and thermoplasty. Eur Respir J. 2018;51(4):1701836. doi:10.1183/13993003.01836-2017.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, Gozalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136(6):1488–1495. doi:10.1016/j.jaci.2015.07.046.
   PubMed Web of Science ®Google Scholar
• Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev. 2000;Cd001740.
   PubMedGoogle Scholar
• Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996;98(6):1051–1057. doi:10.1016/S0091-6749(96)80190-4.
   PubMed Web of Science ®Google Scholar
• Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119(2):405–413. doi:10.1016/j.jaci.2006.11.639.
   PubMed Web of Science ®Google Scholar
• Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M. Oral glucocorticoid–sparing effect of benralizumab in severe asthma. N Engl J Med. 2017;376(25):2448–2458. doi:10.1056/NEJMoa1703501.
   PubMed Web of Science ®Google Scholar
• Nobelprize.org. The Nobel Prize in Physiology or Medicine 1950. Nobel Media AB; 2014 [Last accessed: 28 June 2018]. https://www.nobelprize.org/nobel_prizes/medicine/laureates/1950/.
   Google Scholar
• Ortega HG, Yancey SW, Mayer B, Gunsoy NB, Keene ON, Bleecker ER, Brightling CE, Pavord ID. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. Lancet Respir Med. 2016;4(7):549–556. doi:10.1016/S2213-2600(16)30031-5.
   PubMed Web of Science ®Google Scholar
• Perdoncini-Roux A, Blanchon T, Hanslik T, Lasserre A, Turbelin C, Dorleans Y, Cabane J, Fardet L. General practitioners’ perception of the impact of corticosteroid-induced adverse events. Rev Epidemiol Sante Publique. 2009;57(2):93–97. doi:10.1016/j.respe.2008.12.009.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475–2485. doi:10.1056/NEJMoa1804093.
   PubMed Web of Science ®Google Scholar
• Raïs S, Radoszycki L, Dourgnon P, Rochaix L, Chekroun M. Accurate representation of patients’ opinions for decisionmaking: are online health communities good candidates? 2017. [Last accessed: 30 January 2019]. https://www.carenity.co.uk/static/doc/corporate/poster-ISPOR2017-Accurate-Representation-of-patients-opinions-for-decision-making.pdf.
   Google Scholar
• Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol. 2007;119(4):916–923. doi:10.1016/j.jaci.2006.12.664.
   PubMed Web of Science ®Google Scholar
• Randolph TG, Rollins JP. The effect of cortisone on bronchial asthma. J Allergy. 1950;21(4):288–295. doi:10.1016/0021-8707(50)90060-8.
   PubMedGoogle Scholar
• Rowe BH, Vethanayagam D. The role of inhaled corticosteroids in the management of acute asthma. Eur Respir J. 2007;30(6):1035–1037. doi:10.1183/09031936.00119907.
   PubMed Web of Science ®Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT, Bel EH, Auffray C, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46(5):1308–1321. doi:10.1183/13993003.00779-2015.
   PubMed Web of Science ®Google Scholar
• Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy. 2001;21(12):1464–1467. doi:10.1592/phco.21.20.1464.34485.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116. doi:10.1016/j.jaci.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, Chaudhuri R, Price D, Brightling CE, Heaney LG. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry. Thorax. 2016;71(4):339–346. doi:10.1136/thoraxjnl-2015-207630.
   PubMed Web of Science ®Google Scholar
• van der Palen J, Klein JJ, Zielhuis GA, van Herwaarden CL, Seydel ER. Behavioural effect of self-treatment guidelines in a self-management program for adults with asthma. Patient Educ Couns. 2001;43(2):161–169. doi:10.1016/S0738-3991(00)00155-5.
   PubMed Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long-term OCS therapy and its side effects in severe asthma in adults - a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. doi:10.1183/13993003.00703-2018.
   PubMed Web of Science ®Google Scholar
• Voorham J, Xu X, Price DB, Golam S, Davis J, Zhi Jie Ling J, Kerkhof M, Ow M, Tran TN. Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. 2019;74(2):273–283. doi:10.1111/all.13556.
   PubMed Web of Science ®Google Scholar
• Vuillermin PJ, South M, Carlin JB, Biscan MI, Brennan SL, Robertson CF. Parent-initiated oral corticosteroid therapy for acute asthma: a survey of current practice. J Paediatr Child Health. 2007;43(6):443–445. doi:10.1111/j.1440-1754.2007.01108.x.
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415.
   PubMed Web of Science ®Google Scholar
• Wraight JM, Cowan JO, Flannery EM, Town GI, Taylor DR. Adherence to asthma self-management plans with inhaled corticosteroid and oral prednisone: a descriptive analysis. Respirology. 2002;7(2):133–139. doi:10.1046/j.1440-1843.2002.00374.x.
   PubMed Web of Science ®Google Scholar